Immunoenhancement to prevent nosocomial coagulase-negative staphylococcal sepsis in very low-birth-weight infants.
Clin Perinatol
; 31(1): 69-75, 2004 Mar.
Article
em En
| MEDLINE
| ID: mdl-15183657
Extremely low-birth-weight infants are susceptible to invasion by coagulase-negative staphylococci (CONS). This article reviews the epidemiology, immunology, and microbiology of CONS and describes recent clinical trials of immunoenhancing agents such as intravenous immunoglobulin, granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor, and mouse humanized chimeric anti-lipoteichoic acid antibody. Potential avenues of research to reduce the incidence of nosocomial CONS sepsis in premature neonates are presented.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Infecções Estafilocócicas
/
Staphylococcus
/
Recém-Nascido de Baixo Peso
/
Adjuvantes Imunológicos
/
Infecção Hospitalar
/
Coagulase
Idioma:
En
Ano de publicação:
2004
Tipo de documento:
Article